Search clinical trials for: sinbaro-3
Total 18131 results
-
Ataturk UniversityCompleted3rd Level Intensive Care UnitTurkey
-
Universitaire Ziekenhuizen KU LeuvenCompletedCondition of Patient 3 Years After FESS-operationBelgium
-
SymateseUnknownThird-degree Burns | Reconstructive SurgeryFrance
-
Institute of Vaccines and Medical Biologicals,...Department of Health and Human Services; National Institute of Hygiene and... and other collaboratorsCompleted
-
Keck School of Medicine of USCNot yet recruiting
-
GeropharmCompleted
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Kathmandu University School of Medical SciencesNorwegian University of Science and TechnologyRecruitingUrinary IncontinenceNepal
-
Medical University of WarsawCompletedGestational Diabetes MellitusPoland
-
Cordis CorporationCompleted
-
Gilead SciencesCompleted
-
Centre Hospitalier Universitaire de NiceCompletedAdult Chronic Haemodialysis Patients Since at Least 3 MonthsFrance
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
OFFHEALTH S.p.A.Not yet recruiting
-
3-C Institute for Social DevelopmentCompleted
-
3-C Institute for Social DevelopmentCompletedSubstance-Related DisordersUnited States
-
Centre Oscar LambretUniversité Lille 3Completed
-
Linkoeping UniversityArmauer Hansen Research Institute, Ethiopia; University of GondarCompleted
-
Mahidol UniversityBayer; Chulalongkorn University; Bumrungrad International HospitalCompletedCarcinoma, HepatocellularThailand
-
Linkoeping UniversityKalmar County Hospital; University of GondarCompleted
-
University of North Carolina, Chapel Hill3-C Family ServicesCompleted
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
University Hospital, Strasbourg, FranceUnknown
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, France, Italy, Germany, Spain, Canada, United Kingdom, Australia, Mexico
-
GeropharmCompletedBioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)BioequivalenceRussian Federation
-
GeropharmCompletedBioequivalenceRussian Federation
-
Astellas Pharma IncCompletedKidney TransplantationChina
-
Rabin Medical CenterOmega 3 GalileeRecruiting
-
3-C Institute for Social DevelopmentCompletedSocial Skills | Trauma, Psychological | Family DysfunctionalUnited States
-
3-C Institute for Social DevelopmentCompletedDiabetes Mellitus, Type 1United States
-
3-C Institute for Social DevelopmentCompletedRenal Insufficiency, ChronicUnited States
-
Corregene Biotechnology Co., LtdRecruitingCervical Cancer | Anal Cancer | Head and Neck CancersChina
-
Gomel State Medical UniversityRecruiting
-
NovartisNovartis VaccinesCompleted
-
Novartis VaccinesCompletedSeasonal Influenza, VaccineGermany
-
St George's, University of LondonCompletedCKd Patients With Stage 3 and 4
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
October 6 UniversityCompletedPeriodontitis (Stage 3)Egypt
-
Ataturk UniversityCompletedOxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester AbortionAbortion, Induced | Pregnancy Trimester, Second | Labor Stage, Third/Drug Effects | Oxytocin/Administration & DosageTurkey
-
Holbaek SygehusOdense University HospitalUnknownStability of Clavicular Fractures Within the First 3 WeeksDenmark
-
Eisai Inc.CompletedInsomnia DisorderUnited States, Canada, Finland, Germany, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Spain
-
Riphah International UniversityRecruitingPlanter Fasciitis | Eccentric Heel Drop Training | 3-D Ankle MobilityPakistan
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationCompletedTelemedicine | Reconstructive Surgery | 3 DimensionalUnited Kingdom
-
AstraZenecaActive, not recruitingPart1: Advanced B-cell Malignancies | Part2: r/rCLL and r/rMCL | Part3: Untreated CLLJapan